Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_assertion type Assertion NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_head.
- NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_assertion description "[The mammalian target of rapamycin, which is a sensor of the mitochondrial transmembrane potential, has been successfully targeted for treatment of SLE with rapamycin or sirolimus in both patients and animal models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_provenance.
- NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_assertion evidence source_evidence_literature NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_provenance.
- NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_assertion SIO_000772 20014960 NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_provenance.
- NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_assertion wasDerivedFrom befree-20140225 NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_provenance.
- NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_assertion wasGeneratedBy ECO_0000203 NP718447.RAieQbAb7A0_IFJXtvUXeXavR797C81OIw2pHMsmZEsDc130_provenance.